These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma. Seo JH, Park BC. Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600 [Abstract] [Full Text] [Related]
6. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer. Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H. Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738 [Abstract] [Full Text] [Related]
12. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, Precone DF, Cioffi M, Gaeta GB, Caporaso N, Carella C. Cancer; 2002 Dec 15; 95(12):2539-45. PubMed ID: 12467068 [Abstract] [Full Text] [Related]
14. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan. Chen DS. Princess Takamatsu Symp; 1995 Dec 15; 25():27-32. PubMed ID: 8875606 [Abstract] [Full Text] [Related]
15. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis. Elsammak MY, Amin GM, Khalil GM, Ragab WS, Abaza MM. Clin Biochem; 2006 Jun 15; 39(6):623-9. PubMed ID: 16624274 [Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression. Mas VR, Maluf DG, Stravitz R, Dumur CI, Clark B, Rodgers C, Ferreira-Gonzalez A, Fisher RA. Liver Transpl; 2004 May 15; 10(5):607-20. PubMed ID: 15108252 [Abstract] [Full Text] [Related]
17. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma. Nagata K, Hirono S, Ido A, Kataoka H, Moriuchi A, Shimomura T, Hori T, Hayashi K, Koono M, Kitamura N, Tsubouchi H. Biochem Biophys Res Commun; 2001 Nov 23; 289(1):205-11. PubMed ID: 11708800 [Abstract] [Full Text] [Related]
18. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis. Gramantieri L, Chieco P, Di Tomaso M, Masi L, Piscaglia F, Brillanti S, Gaiani S, Valgimigli M, Mazziotti A, Bolondi L. Clin Cancer Res; 1999 Nov 23; 5(11):3468-75. PubMed ID: 10589760 [Abstract] [Full Text] [Related]
19. Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer. Cariani E, Lasserre C, Kemeny F, Franco D, Brechot C. Hepatology; 1991 Apr 23; 13(4):644-9. PubMed ID: 1707028 [Abstract] [Full Text] [Related]